The Cooper Companies, Inc. $COO Shares Newly Bought by OLD Second National Bank of Aurora

Key Points

• Institutional buying increased: OLD Second National Bank of Aurora purchased 51,833 shares of Cooper Companies worth approximately $2.93 million. Several other major investors also established or expanded positions, though institutions own 24.39% of the stock.
• Analyst sentiment remains cautious: The stock has an average rating of “Hold” from analysts, with an average price target of $68.60; recent ratings included downgrades from Wall Street Zen and William Blair.
• Cooper Companies approved a major buyback: The board authorized a $3 billion share-repurchase program, covering up to 22.7% of outstanding shares. The company also exceeded quarterly EPS expectations, reporting $1.15 versus the $1.12 consensus, despite revenue falling short of estimates.

OLD Second National Bank of Aurora purchased a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 51,833 shares of the medical device company's stock, valued at approximately $2,930,000.

A number of other large investors have also recently made changes to their positions in COO. BlackRock Inc. bought a new stake in Cooper Companies during the second quarter worth approximately $1,077,762,000. Generation Investment Management LLP purchased a new position in shares of Cooper Companies during the second quarter worth approximately $356,304,000. Jupiter Topco LLC bought a new stake in Cooper Companies during the 2nd quarter valued at $305,074,000. JANA Partners Management LP raised its holdings in shares of Cooper Companies by 0.5% in the second quarter. JANA Partners Management LP now owns 3,582,480 shares of the medical device company's stock valued at $256,900,000 after acquiring an additional 17,322 shares in the last quarter. Finally, Wellington Management Group LLP raised its holdings in shares of Cooper Companies by 3.1% in the 2nd quarter. Wellington Management Group LLP now owns 3,468,951 shares of the medical device company's stock valued at $248,758,000 after purchasing an additional 103,044 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Wall Street Zen cut Cooper Companies from a "buy" rating to a "hold" rating in a research note on Saturday, September 12th. William Blair lowered Cooper Companies from an "outperform" rating to a "market perform" rating in a research note on Thursday, September 10th. Wells Fargo & Company set a $61.00 price target on Cooper Companies and gave the stock an "equal weight" rating in a research note on Thursday, September 10th. Mizuho set a $75.00 price objective on shares of Cooper Companies and gave the company an "outperform" rating in a report on Thursday, September 10th. Finally, Robert W. Baird set a $61.00 price objective on shares of Cooper Companies and gave the company a "neutral" rating in a research report on Thursday, September 10th. Four equities research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $68.60.

Cooper Companies Price Performance

NASDAQ COO opened at $61.65 on Friday. The company has a market cap of $11.72 billion, a price-to-earnings ratio of 21.04, a PEG ratio of 2.40 and a beta of 0.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 0.73. The stock's fifty day moving average price is $62.09 and its 200 day moving average price is $65.80. The Cooper Companies, Inc. has a 1 year low of $51.01 and a 1 year high of $89.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Wednesday, September 9th. The medical device company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.12 by $0.03. The company had revenue of $1.07 billion during the quarter, compared to analysts' expectations of $1.10 billion. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%. The firm's revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.49 EPS. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, equities research analysts forecast that The Cooper Companies, Inc. will post 4.53 earnings per share for the current year.

Cooper Companies announced that its board has approved a stock repurchase plan on Wednesday, September 9th that allows the company to buy back $3.00 billion in shares. This repurchase authorization allows the medical device company to repurchase up to 22.7% of its stock through open market purchases. Share repurchase plans are usually a sign that the company's board believes its stock is undervalued.

Insider Buying and Selling

In other Cooper Companies news, Director Lawrence Kurzius purchased 10,000 shares of the business's stock in a transaction that occurred on Wednesday, September 16th. The shares were bought at an average price of $54.93 per share, for a total transaction of $549,300.00. Following the acquisition, the director owned 31,099 shares in the company, valued at $1,708,268.07. This represents a 47.40% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Walter M. Rosebrough, Jr. purchased 3,000 shares of the business's stock in a transaction that occurred on Monday, September 14th. The stock was acquired at an average price of $54.29 per share, for a total transaction of $162,870.00. Following the acquisition, the director owned 20,000 shares in the company, valued at $1,085,800. This trade represents a 17.65% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders bought 34,701 shares of company stock valued at $1,880,039 over the last quarter. 2.08% of the stock is currently owned by company insiders.

About Cooper Companies

CooperCompanies is a global medical device company that develops, manufactures and markets products for vision care and women's health. The company operates through two primary business segments: CooperVision and CooperSurgical.

CooperVision provides contact lenses and related technologies, including products designed for myopia management, astigmatism, presbyopia and other vision-correction needs. Its portfolio includes daily disposable, reusable and specialty contact lenses sold through eye-care professionals and distributors.

CooperSurgical develops products and services for fertility and women's health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.